CNE100000V20
CNE100000V20
ZHIFEI-BIOL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 32.79B EUR | 27.98B EUR | 35.81B EUR | 45.17B EUR |
Enterprise Value | 41.13B EUR | 36.07B EUR | 45.41B EUR | 54.83B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -32.62x | -- | -- | -- |
Price to Sales | 4.07x | 3.47x | 4.09x | 6.84x |
Price to Book | 2.18x | 1.86x | 2.32x | 2.85x |
EV/Revenue | 5.11x | 4.48x | 5.19x | 8.3x |
EV/EBITDA | -2.44x | -- | -- | -- |
Price to FCF (P/FCF) | 2.81x | 7.36x | 10.69x | 13.69x |
EV/FCF | 3.52x | 9.49x | 13.55x | 16.62x |
FCF Yield | 35.59% | 13.58% | 9.36% | 7.3% |